Results of the private placing and listing on the main board of the JSE Limited ASCENDIS HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2008/005856/06) ISIN: ZAE000185005 JSE share code: ASC (“Ascendis” or “the Company”) Results of the private placing and listing on the main board of the JSE Limited Reference is made to the pre-listing statement issued by Ascendis on Friday, 15 November 2013 and the abridged pre-listing statement released on the Securities Exchange News Service on the same date, relating to an offer by Ascendis and certain existing shareholders to select institutional and other investors in South Africa to subscribe for up to 41 163 636 ordinary shares in Ascendis, for cash, at an issue price of R11 per ordinary share, amounting to a capital raise of R452.8 million (“the Private Placing"). The board of directors of Ascendis is pleased to announce that the Private Placing was significantly over- subscribed, and the Company has successfully placed 41 163 636 ordinary shares for an aggregate amount of R452.8 million. All conditions precedent to which the Private Placing and listing was subject, have been fulfilled. The allocated ordinary shares will be transferred to successful applicants on a `delivery-versus- payment` basis on Friday, 22 November 2013. Accordingly, 229 735 527 ordinary shares in Ascendis will be listed in the "Pharmaceuticals" sector of the JSE under the abbreviated name "ASCENDIS" with share code: ASC and ISIN: ZAE000185005, with effect from the commencement of trade on Friday, 22 November 2013. 20 November 2013 Johannesburg Investment Bank, Corporate Advisor and Sponsor Nedbank Capital Date: 20/11/2013 10:51:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.